Respuesta variable a la inhibición biológica de las plaquetas por abciximab en pacientes sometidos a revascularización coronaria percutánea

Galeote, Guillermo; López Pastor, Ángela; Cárcamo, Cristina; Sobrino, Nicolás; Calvo, Luis; García Muñoz, Soledad; Hussein, Monzer; Férnandez Chacón,josé; Sobrino, José.
Rev. esp. cardiol. (Ed. impr.) ; 54(11): 1256-1263, nov. 2001.
Artículo en Es | IBECS (España) | ID: ibc-2307

Documentos relacionados

  1. [Variable response to the biological inhibition of platelets by abciximab in patients subjected to percutaneous coronary angioplasty].
  2. Kinetics of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions.
  3. Label-free multimodal quantitative imaging flow assay for intrathrombus formation in vitro.
  4. Clot Permeability, Agonist Transport, and Platelet Binding Kinetics in Arterial Thrombosis.
  5. Microfluidic assay of antiplatelet agents for inhibition of shear-induced platelet adhesion and activation.
  6. Multiparameter microfluidics assay of thrombus formation reveals increased sensitivity to contraction and antiplatelet agents at physiological temperature.
  7. Human Blood Platelets Adsorption on Polymeric Materials for Liquid Biopsy.
  8. Regulation of Human Platelet Adhesion with Ascorbic Acid.
  9. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists.
  10. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.